Navigation Links
Merrimack Pharmaceuticals' Preclinical Research Shows MM-111 Restores Sensitivity To Chemotherapy And HER2-targeted Treatment In Gastric Cancer Model
Date:4/10/2013

tric, esophageal and ovarian cancers. 

Study Results

Results of the preclinical study showed that the combination of MM-111 with trastuzumab is synergistic in a preclinical HER2-expressing gastric cancer model. Additionally, the study found that heregulin desensitizes gastric tumor cells to the effects of trastuzumab and paclitaxel.  The addition of MM-111 to the paclitaxel and trastuzumab regimen, or the addition of MM-111 to either paclitaxel or trastuzumab, restored sensitivity of tumors to treatment in the model.

About Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies Network Biology, its proprietary systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has six targeted therapeutic oncology candidates in clinical development.

Forward-Looking Statement
To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements include any statements about Merrimack's strategy, future operations, future financial position and future expectations and plans and prospects for Merrimack, and any other statements containing the words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions. In this press release, Merrimack's forward-looking statements include statements about the potential effectiveness of its drug candidates and its ability to translate preclinic
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
2. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
3. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
4. Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device
5. Faruqi & Faruqi, LLP is Investigating Peregrine Pharmaceuticals Inc. on Behalf of its Shareholders - PPHM
6. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
7. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
8. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
9. Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Regeneron Pharmaceuticals Announces Expansion in New Yorks Hudson Valley
11. Valeant Pharmaceuticals Provides Update to Recent Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  St. Vincent Healthcare ... patient care. Already following strict disinfection routines, St. ... SmartUVC to eliminate harmful germs, like Ebola, methicillin-resistant ... norovirus that can infect patients during their hospital ... Logo - http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
(Date:4/21/2015)... 2015 Legal cannabis markets, products ... at a rapid pace over the next five years ... services for indoor/outdoor cultivators and new cannabis products for ... (OTC: SRNA), Totally Hemp Crazy Inc. (OTC: THCZ), Medical ... 22 nd Century Group, Inc. (NYSE: XXII ...
(Date:4/21/2015)... -- IntelliQuit™, the world,s first smartphone breathalyzer for smokers, was selected to present as a finalist at ... on Wednesday April 22.  Photo ... ... ... Thirty percent (30%) of all cardiovascular disease is caused by smoking. The ...
Breaking Medicine Technology:St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 2New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 3New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 4New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 5New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 6New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 7IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 2IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 3
(Date:4/21/2015)... 2015 Patients seeking surgical treatment for ... choice for receiving treatment at a nationally accredited program ... quality of care in the greater Tampa area. ... center has been accredited as a Comprehensive Center under ... Program (MBSAQIP), a joint program of the American College ...
(Date:4/21/2015)... 21, 2015 Henry Mayo Newhall Hospital, ... Care Exchange to automatically send continuation of care ... to further improve communication with clinics and other ambulatory ... Alert solution. , “Provider Alert will enable ... patient information they need to provide continuing care in ...
(Date:4/21/2015)... “ ZeroWire ” was featured on ... takes a look at the latest and coolest technology ... special reporter for NewsWatch and a technology expert, conducted ... a security system and lifestyle management hub. , According ... 2 million burglaries in 2010. It goes without saying ...
(Date:4/21/2015)... BC (PRWEB) April 21, 2015 Angelo’s ... complimentary pick-up and delivery for clients that avail the ... Surrey by Angelo’s is done with hi-tech equipments, making ... for customers. They use all natural, high pressure steam ... well as hand washing for area rugs made with ...
(Date:4/21/2015)... Lowcostcarinsuranceprice.com has released a new blog post explaining how ... , SUVs are large vehicles that fare well in ... a smaller regular car shows that passengers from the first ... safer in crashes, but these large vehicles may be unstable ... It is now possible to find low cost car insurance ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 2Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 3Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 4Health News:Henry Mayo Newhall Hospital to Improve Ambulatory Information Sharing with Summit Healthcare's Summit Provider Alert 2Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Auto Insurance Quotes For SUVs Are Available Online 2
... Treatment that increases brain levels of an important regulatory ... characterizes Huntington,s disease (HD) and other neurodegenerative disorders. ... Nature Medicine , a Massachusetts General Hospital (MGH)-based research ... a family of enzymes called sirtuins, in the brain ...
... The busy holiday season may disrupt many people,s daily routines, ... to remember to look after your teeth, an expert advises. ... treats and drink alcoholic beverages more than usual," Dr. George ... an academy news release. "Additionally, with their busy schedules ...
... Accelerated partial breast irradiation using brachytherapy (APBIb) for ... increasing over the last several years in the ... (WBI), according to a study published December 16th ... Cancer Institute . Various types of APBI ...
... , FRIDAY, Dec. 16 (HealthDay News) -- ,Draft recommendations ... trials for medical devices were released Friday by the ... size, diet, social and cultural factors, and types of ... medical products and devices than men, according to the ...
... scientists at the University of California, San Francisco has ... disorder called PKD/IC, or "paroxysmal kinesigenic dyskinesia with infantile ... disorders in older children. The study involved clinics ... London and Istanbul and may improve the ability of ...
... 16 (HealthDay News) -- Chronic pain can hinder communication ... partner,s ability to cope with the pain, according to ... validation of a spouse,s emotions (showing respect and acceptance) ... emotions (showing hostility or no interest) increases emotional distance ...
Cached Medicine News:Health News:Regulatory enzyme overexpression may protect against neurodegeneration in Huntington's disease 2Health News:Dentist Gives Advice to Keep Holiday Smiles Bright 2Health News:Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy 2Health News:Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy 3Health News:FDA Seeks to Get More Women Into Trials of Medical Devices 2Health News:UCSF-led team discovers cause of rare disease 2Health News:Spouse's Reaction May Affect Pain Management 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: